News | April 16, 2007

Signalife Fine Tunes Distribution Strategy

April 17, 2007 — Signalife has announced it has hired a new distribution organization for its Fidelity 100 product line. The group consists of independent distributor reps for cardiac rhythm management products (ICDs and pacemakers).

The initial focus will be the Southern region from North Carolina to Texas, but additional representation is already under consideration in other areas of the country. The initial number of sales representatives will start at 25 and may increase to 50 before year-end.

"This is a very exciting development for Signalife as the independent representatives are experienced and understand the significance of our technology and product. They have existing relationships with physicians and hospitals that mirror the desired call points for our company. We are pleased to complete phase one of this distribution channel, and look forward to results created by a professional sales force within the industry," stated Pamela Bunes, CEO of Signalife, Inc.


Related Content

News | Pacemakers

March 26, 2024 — UC San Diego Health is the first health system in San Diego to successfully implant the world’s first ...

Home March 26, 2024
Home
News | Pacemakers

March 15, 2024 — Following the recent CE approval of the Solia S lead1 for LBBAP, BIOTRONIK proudly announces the world ...

Home March 15, 2024
Home
News | Pacemakers

March 15, 2024 — Following the recent CE approval of the Solia S lead1 for LBBAP, Biotronik announces the world’s first ...

Home March 15, 2024
Home
News | Pacemakers

January 5, 2024 — Medtronic, a global leader in healthcare technology, today announced it has received CE (Conformité ...

Home January 05, 2024
Home
News | Pacemakers

August 21, 2023 — The first implant in Europe of Biotronik’s latest pacemaker and CRT-P generation was conducted in ...

Home August 21, 2023
Home
News | Pacemakers

July 6, 2023 — BIOTRONIK announced U.S. Food and Drug Administration (FDA) approval of its portfolio of Amvia Edge ...

Home July 06, 2023
Home
News | Pacemakers

July 5, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR dual chamber (DR ...

Home July 05, 2023
Home
News | Pacemakers

June 1, 2023 — Every year more than one million people receive a pacemaker. Until now, leadless versions were only ...

Home June 01, 2023
Home
News | Pacemakers

May 25, 2023 — Abbott announced late-breaking results from the AVEIR dual-chamber (DR) i2i Investigational Device ...

Home May 25, 2023
Home
News | Pacemakers

May 12, 2023 — Biotronik, a leading global medical technology company with 60 years of experience in developing trusted ...

Home May 12, 2023
Home
Subscribe Now